Research progress on osteoclast regulation by biodegradable magnesium and its mechanism
Regenerative Biomaterials · 06.01.2025 · 12
DOI: 10.1093/rb/rbaf026 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Biomaterials, online erschienen am 26.04.2025. Verfasst von Wangwei Zhu und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 180 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dalian Key Medical Specialties “Peak Climbing” Program, China Postdoctoral Science Foundation, Dongguan Science and Technology of Social Development Program.
Abstract (Originalsprache)
Continuous advancements in medical technology and biomaterials have underscored the significant advantages of biodegradable implant materials for bone repair and remodelling over traditional inert metallic implants. Notably, biodegradable magnesium-based materials have gained much attention because of their optimal corrosion rates. Importantly, extensive clinical experience has resulted in the use of biodegradable magnesium-based orthopaedic implants. Both preclinical and clinical studies have consistently demonstrated that Mg has an excellent ability to promote bone tissue formation, a process that is closely associated with the release of Mg2+ and other degradation byproducts. Bone metabolism depends on a dynamic balance of bone formation and bone resorption. Mg2+ has been shown to increase osteoblast (OB) activity while suppressing osteoclast (OC) formation, thus playing a crucial role in bone remodelling and regeneration. In terms of osteolysis inhibition, Mg2+ plays a multifaceted role. First, Mg2+ inhibits OC formation by modulating the activity of mature OCs, their migratory behaviour and the activity of precursor cells. Second, Mg2+ influences OC production by regulating the expression of osteoprotegerin (OPG), receptor activator of nuclear factor kappa-Β ligand (RANKL) and nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB). Additionally, Mg2+ impacts bone resorption by altering the immune microenvironment and the levels of hormones and peptides within the body. Furthermore, the alkaline environment generated around the biodegradable magnesium implant and its degradation products (e.g. H2) also significantly inhibit OC formation. Recent research on magnesium-based implants has focused predominantly on their osteogenic properties, with few systematic reviews addressing the mechanisms through which biodegradable magnesium alloys suppress osteoclastic activity. This article summarizes the latest clinical research progress concerning biodegradable magnesium implant materials and their significant regulatory effects and discusses recent advances in the understanding of the regulatory mechanisms of action Mg-based biomaterials on OCs, with the aim of providing a more theoretical basis for the clinical application of biodegradable magnesium-based implants.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopedics, Affiliated Zhongshan Hospital of Dalian University, Dalian 116001, China.
- Orthopedic Medical Research Center, Dalian University, Dalian 116622, China.
- Institute of Metal Research, Chinese Academy of Sciences, Shenyang 110016, China.
- School of Materials Science and Engineering, Dongguan University of Technology, Dongguan 523808, China.
- Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong SAR 999077, China.
Förderung
- Dalian Key Medical Specialties “Peak Climbing” Program
- China Postdoctoral Science Foundation
- Dongguan Science and Technology of Social Development Program
- Youth Star of Science and Technology of Dalian
- Liaoning Provincial Science and Technology Plan Joint Plan
- Dalian Life and Health Sector Guidance Program
Zitieren
APA
Zhu, W., Wang, W., Yang, X., Ran, C., Zhang, T., Huang, S., Yang, J., Wang, F., Wang, H., Wan, P., Piao, F., Lu, F., Shi, S., Li, Y., Zhang, X., & Zhao, D. (2025). Research progress on osteoclast regulation by biodegradable magnesium and its mechanism. Regenerative Biomaterials, 12. https://doi.org/10.1093/rb/rbaf026
Vancouver
Zhu W, Wang W, Yang X, Ran C, Zhang T, Huang S, et al. Research progress on osteoclast regulation by biodegradable magnesium and its mechanism. Regenerative Biomaterials. 2025;12. doi:10.1093/rb/rbaf026
BibTeX
@article{Zhu2025,
author = {Zhu, Wangwei and Wang, Weidan and Yang, Xing and Ran, Chunxiao and Zhang, Tianwei and Huang, Shibo and Yang, Jiahui and Wang, Fuyang and Wang, Huiya and Wan, Peng and Piao, Fengyuan and Lu, Faqiang and Shi, Shengbo and Li, Ye and Zhang, Xiuzhi and Zhao, Dewei},
title = {Research progress on osteoclast regulation by biodegradable magnesium and its mechanism},
journal = {Regenerative Biomaterials},
year = {2025},
volume = {12},
doi = {10.1093/rb/rbaf026}
}
EUVIMED